Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
Nautilus Biotechnology (NASDAQ:NAUT) will release its second quarter 2026 financial results before market open on Tuesday, July 28, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nautilus Biotechnology (NASDAQ:NAUT) will release its second quarter 2026 financial results before market open on Tuesday, July 28, 2026.
Management will host a webcast conference call at 5:30 a.m. PT / 8:30 a.m. ET to discuss results, business developments, and outlook, accessible via the company’s investor website.
Details
Market move: NAUT +5.33% in the Jul 8 session. 2Q26 earnings date
On Jul 8, the day this news came out, NAUT closed 5.33% above the previous close. Argus tracked a peak move of +8.5% during that session. Our momentum scanner recorded 10 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 8 session.
Key Figures
- Earnings date
- July 28, 2026
- Second quarter 2026 results release before market open
- Conference call time
- 5:30 a.m. PT
- Management webcast to discuss Q2 2026 results
- Conference call time
- 8:30 a.m. ET
- Management webcast to discuss Q2 2026 results
Previous Earnings date Reports
-
Announced Q1 2026 earnings release timing and related webcast details.
-
Set date for Q4 and full-year 2025 financial results and conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the second quarter 2026 before market open on Tuesday, July 28, 2026.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.